Robuta

https://findtrial.co/trial/ACTRN12606000140550 An Open-Label, Non-Comparative Expanded Access Study of the Raf-Kinase Inhibitor Sorafenib as a... This is a non-randomised, open-label treatment protocol for patients with advanced renal cell carcinoma, who received previous systemic therapy for advanced... open label expanded access of the raf kinase non https://ris.medunigraz.at/de/activities/overexpression-of-mir-23a-mir-24-and-mir-15a-in-acute-myeloid-leu/ Overexpression of miR-23a, miR-24 and miR-15a in acute myeloid leukemia with loss of the RAF kinase... acute myeloid leukemia raf kinase overexpression mir loss